• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Etiology and Features of Eyes with Rubeosis Iridis among Korean Patients: A Population-Based Single Center Study.韩国患者虹膜红变眼的病因及特征:一项基于人群的单中心研究
PLoS One. 2016 Aug 4;11(8):e0160662. doi: 10.1371/journal.pone.0160662. eCollection 2016.
2
Neovascular complications associated with rubeosis iridis and peripheral retinal detachment after retinal detachment surgery.视网膜脱离手术后与虹膜红变和周边视网膜脱离相关的新生血管并发症。
Am J Ophthalmol. 1998 Sep;126(3):379-89. doi: 10.1016/s0002-9394(98)00093-2.
3
[Differences of ocular circulation in eyes with proliferative diabetic retinopathy after panretinal photocoagulation with and without rubeosis iridis].[增殖性糖尿病视网膜病变患者行全视网膜光凝后有无虹膜新生血管时眼循环的差异]
Nippon Ganka Gakkai Zasshi. 2009 Jan;113(1):11-5.
4
Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment.糖尿病玻璃体切除术后急性虹膜红变可能提示周边牵引性视网膜脱离。
Ger J Ophthalmol. 1992;1(6):375-81.
5
Iridopathy in eyes with proliferative diabetic retinopathy: detection of early stage of rubeosis iridis.
Ophthalmologica. 1998;212(1):15-8. doi: 10.1159/000027252.
6
Dilation of the minor arterial circle of the iris preceding rubeosis iridis during retinal vein occlusion.视网膜静脉阻塞期间虹膜红变之前虹膜小动脉环的扩张。
Am J Ophthalmol. 2004 Dec;138(6):1083-6. doi: 10.1016/j.ajo.2004.06.080.
7
Rubeosis iridis and neovascular glaucoma: II. Our own experiences with the treatment by cryocoagulation.虹膜红变与新生血管性青光眼:II. 我们自身的冷冻凝固治疗经验。
Acta Univ Palacki Olomuc Fac Med. 1992;134:105-8.
8
[Rubeosis iridis following pars plana vitrectomy (author's transl)].
Klin Monbl Augenheilkd. 1980 Jul;177(1):24-30. doi: 10.1055/s-2008-1057605.
9
Regression of diabetic rubeosis iridis following successful surgical reattachment of the retina by vitrectomy.玻璃体切除术后视网膜成功复位后糖尿病性虹膜红变消退
Retina. 1982;2(4):193-6.
10
[Clinical correlation between rubeosis iridis and optic disc neovascularization (author's transl)].虹膜红变与视盘新生血管形成之间的临床关联(作者译)
J Fr Ophtalmol. 1981;4(5):405-10.

引用本文的文献

1
The Potential Effects of Light Irradiance in Glaucoma and Photobiomodulation Therapy.光照强度在青光眼及光生物调节疗法中的潜在影响
Bioengineering (Basel). 2023 Feb 7;10(2):223. doi: 10.3390/bioengineering10020223.
2
Severe carotid stenosis presenting as ipsilateral ocular ischaemic syndrome: successful treatment with carotid artery stenting.表现为同侧眼部缺血综合征的严重颈动脉狭窄:颈动脉支架置入术成功治疗
Singapore Med J. 2021 Dec;62(12):667-669. doi: 10.11622/smedj.2020160. Epub 2020 Nov 30.
3
Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy.探讨 UPARANT 在与增生性视网膜病变相关的小鼠模型中对虹膜新生血管的抑制作用。
J Mol Med (Berl). 2020 Nov;98(11):1629-1638. doi: 10.1007/s00109-020-01979-8. Epub 2020 Sep 17.
4
The uPAR System as a Potential Therapeutic Target in the Diseased Eye.尿激酶型纤溶酶原激活物系统作为病变眼中的潜在治疗靶点。
Cells. 2019 Aug 18;8(8):925. doi: 10.3390/cells8080925.
5
UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis.UPARANT 是一种有效的抗血管生成药物,可用于治疗虹膜新生血管的小鼠模型。
J Mol Med (Berl). 2019 Sep;97(9):1273-1283. doi: 10.1007/s00109-019-01794-w. Epub 2019 Jun 26.
6
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis.穿刺诱导的虹膜新生血管形成作为虹膜红变的小鼠模型。
J Vis Exp. 2018 Mar 8(133):57398. doi: 10.3791/57398.
7
Neovascularization of the iris in retinoschisis.
Am J Ophthalmol Case Rep. 2017 Jun 22;7:99-101. doi: 10.1016/j.ajoc.2017.06.019. eCollection 2017 Sep.
8
A novel in vivo model of puncture-induced iris neovascularization.一种新型的穿刺诱导虹膜新生血管形成的体内模型。
PLoS One. 2017 Jun 28;12(6):e0180235. doi: 10.1371/journal.pone.0180235. eCollection 2017.

本文引用的文献

1
Neovascular glaucoma: a retrospective review from a tertiary center in China.新生血管性青光眼:来自中国一家三级中心的回顾性研究。
BMC Ophthalmol. 2016 Jan 27;16:14. doi: 10.1186/s12886-016-0190-8.
2
Prevalence and types of glaucoma among an indigenous African population in southwestern Nigeria.尼日利亚西南部一个非洲土著人群中的青光眼患病率和类型。
Invest Ophthalmol Vis Sci. 2013 Nov 11;54(12):7410-6. doi: 10.1167/iovs.13-12698.
3
The prevalence and types of glaucoma in an urban Indian population: the Singapore Indian Eye Study.城市印度人群中的青光眼患病率和类型:新加坡印度人眼研究。
Invest Ophthalmol Vis Sci. 2013 Jul 10;54(7):4621-7. doi: 10.1167/iovs.13-11950.
4
Ocular ischemic syndrome - a systematic review.眼缺血综合征 - 系统评价。
Med Sci Monit. 2012 Aug;18(8):RA138-144. doi: 10.12659/msm.883260.
5
Neovascular glaucoma: a retrospective review of 5-year experience in Songklanagarind Hospital.新生血管性青光眼:宋卡王子大学素叻他尼医院5年经验的回顾性研究
J Med Assoc Thai. 2012 Apr;95 Suppl 4:S36-42.
6
Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective.不同种族人群中糖尿病视网膜病变的患病率:全球视角。
Surv Ophthalmol. 2012 Jul-Aug;57(4):347-70. doi: 10.1016/j.survophthal.2012.01.004. Epub 2012 Apr 28.
7
The prevalence of glaucoma in indigenous Australians within Central Australia: the Central Australian Ocular Health Study.澳大利亚中部地区原住民的青光眼患病率:澳大利亚中部眼部健康研究。
Br J Ophthalmol. 2012 Feb;96(2):162-6. doi: 10.1136/bjo.2010.196642. Epub 2011 Apr 22.
8
Neovascular glaucoma at king khaled eye specialist hospital - etiologic considerations.沙特国王哈立德眼科专科医院的新生血管性青光眼——病因学考量
Middle East Afr J Ophthalmol. 2009 Jan;16(1):15-9. doi: 10.4103/0974-9233.48860.
9
The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.视网膜静脉阻塞的患病率:来自美国、欧洲、亚洲和澳大利亚的人群研究的汇总数据。
Ophthalmology. 2010 Feb;117(2):313-9.e1. doi: 10.1016/j.ophtha.2009.07.017.
10
Bevacizumab in glaucoma: a review.贝伐单抗在青光眼治疗中的应用综述。
Can J Ophthalmol. 2007 Dec;42(6):812-5. doi: 10.3129/i07-160.

韩国患者虹膜红变眼的病因及特征:一项基于人群的单中心研究

Etiology and Features of Eyes with Rubeosis Iridis among Korean Patients: A Population-Based Single Center Study.

作者信息

Jeong Yun Cheol, Hwang Young Hoon

机构信息

Department of Ophthalmology, Konyang University, Kim's Eye Hospital, Myung-Gok Eye Research Institute, Seoul, Korea.

出版信息

PLoS One. 2016 Aug 4;11(8):e0160662. doi: 10.1371/journal.pone.0160662. eCollection 2016.

DOI:10.1371/journal.pone.0160662
PMID:27490797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4973984/
Abstract

PURPOSE

To estimate the etiology and features of the eyes with rubeosis iridis among Korean patients.

MATERIALS AND METHODS

This study is a retrospective review of 533 Korean patients with rubeosis iridis who visited an eye hospital in Seoul, Korea. We defined rubeosis iridis as visible blood vessels on the iris surface detected during a slit-lamp examination. All cases were reviewed for age at the time of diagnosis, medical history, the most likely cause of rubeosis iridis, visual acuity, and intraocular pressure.

RESULTS

The most commonly observed cause of rubeosis iridis was diabetic retinopathy (DR; n = 337, 63.2%), followed by retinal vein occlusion (RVO; n = 101, 18.9%), ocular ischemic syndrome (OIS; n = 24, 4.5%), retinal detachment (n = 17, 3.2%), and uveitis (n = 15, 2.8%). The cause was classified as miscellaneous in 18 cases (3.4%); in 21 eyes (3.9%), the cause was not clear. Age at the time of rubeosis iridis diagnosis was lower in patients with DR (56.5 years) than in those with RVO (61.0 years) and OIS (64.8 years; P < 0.01). Intraocular pressure of the eyes with DR (37.3 mmHg) and RVO (39.5 mmHg) was higher than that of the eyes with OIS (25.8 mmHg; P < 0.01).

CONCLUSION

In our population-based single center study, DR was the leading cause of rubeosis iridis followed by RVO and OIS among Korean patients. The clinical characteristics of the eyes with rubeosis iridis differed according to etiology. This finding may be useful when assessing eyes with rubeosis iridis.

摘要

目的

评估韩国患者虹膜红变的病因及特征。

材料与方法

本研究对533例就诊于韩国首尔一家眼科医院的韩国虹膜红变患者进行回顾性分析。我们将虹膜红变定义为裂隙灯检查时在虹膜表面可见的血管。所有病例均回顾了诊断时的年龄、病史、虹膜红变最可能的病因、视力和眼压。

结果

虹膜红变最常见的病因是糖尿病视网膜病变(DR;n = 337,63.2%),其次是视网膜静脉阻塞(RVO;n = 101,18.9%)、眼部缺血综合征(OIS;n = 24,4.5%)、视网膜脱离(n = 17,3.2%)和葡萄膜炎(n = 15,2.8%)。18例(3.4%)病因分类为其他;21只眼(3.9%)病因不明。DR患者虹膜红变诊断时的年龄(56.5岁)低于RVO患者(61.0岁)和OIS患者(64.8岁;P < 0.01)。DR组(37.3 mmHg)和RVO组(39.5 mmHg)的眼压高于OIS组(25.8 mmHg;P < 0.01)。

结论

在我们基于人群的单中心研究中,DR是韩国患者虹膜红变的主要病因,其次是RVO和OIS。虹膜红变患者的临床特征因病因不同而有所差异。这一发现可能有助于评估虹膜红变患者。